Advances in Clinical Chemistry, Volume 44
Volume forty-four of the Advances in Clinical Chemistry series contains review articles of wide interest to clinical laboratory scientists and diagnostic adventurers. Articles in this volume cover such topics as Caspases in Myocardial Infarction; Deamidated Gliadin Peptides as Targets for Celiac Disease Specific Antibodies; Urokinase Receptor Variants in Tissue and Body Fluids; Proteomics in Cancer; Paraneoplastic Neurological Syndromes and Oncnerual Antibodies: Clinical and Immunological Aspects; Pathophysiologic Mechanisms of Angiogenesis; Bikunin (Urinary Trypsin Inhibitor): Structure, Biological Relevance and Measurement; and Gene Expression Assays.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Deamidated Gliadin Peptides as Targets for Celiac DiseaseSpecific Antibodies
Urokinase Receptor Variants in Tissue and Body Fluids
Proteomics in Cancer
Paraneoplastic Neurological Syndromes And Onconeural Antibodies Clinical And Immunological Aspects
2D‐PAGE angiogenesis angiogenic angiogenic factors antigen apoptosis apoptotic assay associated autoantibodies aVected binding Biochem Biol Chem biomarkers blood breast cancer cancer cells cancer patients carcinoma cardiomyocytes caspase caspase inhibitor caspase‐3 CD patients celiac disease cell death cell lines cell surface cellular cleavage cleaved Clin clinical deamidated detection diagnostic disorders diVerent diVerentially expressed domain ELISA endothelial cells enzyme epitope eVect expression profile function gene expression gliadin gliadin antibodies gliadin peptides Hoyer‐Hansen G human identified immune Immunol inflammation inflammatory inhibition kinase levels lung cancer mAbs malignant markers membrane mice microarray molecular molecules myocardial neuronal neuropathy neutrophil normal onconeural antibodies paraneoplastic cerebellar degeneration paraneoplastic neurological pathways peptides plasma plasmin prognostic prostate proteases protein proteomic proteomic studies reperfusion response role samples SCLC sequence serum signaling specific suPAR symptoms syndrome target therapy tissue transglutaminase trypsin tumor uPAR uPAR(I uPAR(I–III urokinase receptor urokinase‐type plasminogen activator VEGF
Page 283 - Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC...